Based on this, we assume that endogenous N-myc expression level of NB cells may not correlate with their responsiveness to VPA-induced NCAM upregulation, and VPA-induced loss of N-myc may be limited to CDDP-resistant and drug-sensitive tumour cells. The gene discussed is NCAM1; the disease is neoplasm.